Capricor Therapeutics Inc (CAPR)
6.35
+0.05
(+0.79%)
USD |
NASDAQ |
May 21, 09:48
Capricor Therapeutics Free Cash Flow: -33.33M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -33.33M |
| December 31, 2023 | -27.64M |
| September 30, 2023 | -23.45M |
| June 30, 2023 | -20.80M |
| March 31, 2023 | -18.11M |
| December 31, 2022 | 1.557M |
| September 30, 2022 | 3.685M |
| June 30, 2022 | 6.664M |
| March 31, 2022 | 8.782M |
| December 31, 2021 | -18.01M |
| September 30, 2021 | -16.14M |
| June 30, 2021 | -15.46M |
| March 31, 2021 | -12.75M |
| December 31, 2020 | -10.60M |
| September 30, 2020 | -8.257M |
| June 30, 2020 | -6.779M |
| March 31, 2020 | -6.432M |
| December 31, 2019 | -6.822M |
| September 30, 2019 | -8.792M |
| June 30, 2019 | -10.27M |
| March 31, 2019 | -12.18M |
| December 31, 2018 | -14.18M |
| September 30, 2018 | -13.09M |
| June 30, 2018 | -13.17M |
| March 31, 2018 | -13.19M |
| Date | Value |
|---|---|
| December 31, 2017 | -14.26M |
| September 30, 2017 | -15.18M |
| June 30, 2017 | -13.90M |
| March 31, 2017 | -15.10M |
| December 31, 2016 | -14.65M |
| September 30, 2016 | -14.71M |
| June 30, 2016 | -16.12M |
| March 31, 2016 | -13.11M |
| December 31, 2015 | -10.97M |
| September 30, 2015 | -9.483M |
| June 30, 2015 | -8.405M |
| March 31, 2015 | -12.57M |
| December 31, 2014 | 0.7721M |
| September 30, 2014 | 3.147M |
| June 30, 2014 | 0.8581M |
| March 31, 2014 | 6.240M |
| December 31, 2013 | -6.200M |
| September 30, 2013 | -6.525M |
| June 30, 2013 | -2.478M |
| March 31, 2013 | -2.650M |
| December 31, 2012 | -2.063M |
| September 30, 2012 | -3.520M |
| June 30, 2012 | -3.677M |
| March 31, 2012 | -3.992M |
| December 31, 2011 | -4.649M |
Free Cash Flow Range, Past 5 Years
-33.33M
Minimum
Mar 2024
8.782M
Maximum
Mar 2022
-11.15M
Average
-10.44M
Median
Free Cash Flow Benchmarks
| Sarepta Therapeutics Inc | -653.88M |
| PTC Therapeutics Inc | -199.47M |
| Solid Biosciences Inc | -92.54M |
| Inovio Pharmaceuticals Inc | -116.52M |
| Stereotaxis Inc | -8.683M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.268M |
| Cash from Investing (Quarterly) | -9.502M |
| Cash from Financing (Quarterly) | 2.290M |
| Free Cash Flow Per Share (Quarterly) | -0.0616 |
| Free Cash Flow to Equity (Quarterly) | -1.933M |
| Free Cash Flow Yield | -18.55% |